Bernard Učakar
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 11
- Immunology 14
- Immunotherapy and Immune Responses 8
- Immune cells in cancer 5
- Co-authors
- Véronique Préat (32 shared papers)Fabienne Danhier (12 shared papers)Anne des Rieux (16 shared papers)Bernard Gallez (11 shared papers)Patrick B. Memvanga (3 shared papers)Régis Coco (2 shared papers)Kévin Vanvarenberg (19 shared papers)Rita Vanbever (12 shared papers)
- Journals
- International Journal of Pharmaceutics (13 papers)Journal of Controlled Release (9 papers)European Journal of Pharmaceutics and Biopharmaceutics (3 papers)PLoS ONE (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Bernard Učakar
53 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 113
- Biomaterials 926
- Pharmaceutical Science 403
- Molecular Medicine 237
- Rehabilitation 126
- Genetics 195
Countries citing papers authored by Bernard Učakar
This map shows the geographic impact of Bernard Učakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Učakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Učakar more than expected).
Fields of papers citing papers by Bernard Učakar
This network shows the impact of papers produced by Bernard Učakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Učakar. The network helps show where Bernard Učakar may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Učakar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 228 | |
| 2 | 2014 | 192 | |
| 3 | 2014 | 180 | |
| 4 | 2013 | 179 | |
| 5 | 2017 | 128 | |
| 6 | 2016 | 110 | |
| 7 | 2010 | 108 | |
| 8 | 2013 | 85 | |
| 9 | 2004 | 76 | |
| 10 | 2018 | 73 | |
| 11 | 2016 | 60 | |
| 12 | 2009 | 55 | |
| 13 | 2013 | 50 | |
| 14 | 2020 | 44 | |
| 15 | 2015 | 41 | |
| 16 | 2017 | 37 | |
| 17 | 2018 | 36 | |
| 18 | 2023 | 36 | |
| 19 | 2019 | 36 | |
| 20 | 2010 | 35 |
About Bernard Učakar
Bernard Učakar is a scholar working on Biomaterials, Immunology, Biomedical Engineering, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (9 papers), Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (6 papers), Neurogenesis and neuroplasticity mechanisms (5 papers), Inhalation and Respiratory Drug Delivery (5 papers), Immune cells in cancer (5 papers) and Nerve injury and regeneration (5 papers). The work is most often cited by research in Biomaterials (926 citations), Pharmaceutical Science (403 citations), Molecular Medicine (237 citations), Rehabilitation (126 citations) and Genetics (195 citations). Bernard Učakar has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Véronique Préat, Fabienne Danhier, Anne des Rieux, Bernard Gallez, Patrick B. Memvanga, Régis Coco, Kévin Vanvarenberg, Rita Vanbever, Gaëlle Vandermeulen and Ana Beloqui. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.